The Growing Challenge of Pharmaceutical Contaminants in Water

Pharmaceuticals in wastewater represent a mounting environmental and public health challenge. These compounds, including antibiotics, analgesics, hormones, and antidepressants, enter water systems through human excretion, improper disposal of unused medications, and industrial discharge. Unlike many traditional pollutants, pharmaceuticals are designed to be biologically active at low concentrations, making their presence in water bodies a concern even at trace levels. Studies have detected these compounds in rivers, lakes, and even drinking water sources, raising questions about long-term human health effects and ecosystem disruption. Conventional wastewater treatment plants, which primarily target organic matter, nutrients, and pathogens, are often not designed to remove these micropollutants. As a result, pharmaceutical residues persist and accumulate in the environment, contributing to issues such as antibiotic resistance in bacteria and endocrine disruption in aquatic wildlife.

Among the technologies being explored to address this gap, activated carbon has gained significant attention for its ability to adsorb a wide variety of organic contaminants, including pharmaceuticals. Its high surface area, porous structure, and relatively low cost make it a practical option for both upgrading existing treatment plants and designing new systems. This article provides an in-depth look at the potential of activated carbon for pharmaceutical removal, covering its mechanisms, practical considerations, and future prospects.

Understanding Activated Carbon: Structure and Production

Activated carbon is a processed form of carbon with a highly developed internal pore network that gives it an exceptionally large surface area per unit mass. Typical surface areas range from 500 to 1,500 m²/g, enabling it to trap molecules through physical adsorption. The raw materials used for production include coconut shells, wood, coal (anthracite or bituminous), and peat. The production process involves two main stages: carbonization and activation.

Carbonization

In carbonization, the raw material is heated to high temperatures (400–900 °C) in the absence of oxygen. This removes volatile components and leaves a carbon-rich char with a rudimentary pore structure. The char has some adsorption capacity, but it is relatively low.

Activation

Activation increases the porosity and surface area. There are two primary activation methods: thermal (physical) activation and chemical activation. In thermal activation, the char is exposed to oxidizing gases such as steam, carbon dioxide, or air at temperatures above 800 °C. This burns off decomposition products and creates micropores. Chemical activation involves impregnating the raw material with a chemical agent (e.g., phosphoric acid, zinc chloride, potassium hydroxide) before carbonization. The chemical agent promotes pore formation at lower temperatures and often yields a higher proportion of mesopores. The choice of raw material and activation method influences the pore size distribution, surface chemistry, and adsorption characteristics of the final product.

Key Properties for Pharmaceutical Adsorption

Not all activated carbons are equally effective for pharmaceutical removal. Important properties include pore size distribution (micropores < 2 nm, mesopores 2–50 nm, macropores > 50 nm), surface functional groups (e.g., carboxyl, hydroxyl, lactone), and specific surface area. Pharmaceuticals are relatively large organic molecules, so mesopores often play a crucial role in allowing access to micropores and providing binding sites. Additionally, the surface chemistry can be modified to enhance interactions with specific pharmaceutical classes, such as basic or acidic compounds.

Mechanisms of Pharmaceutical Removal by Activated Carbon

Activated carbon removes pharmaceutical compounds primarily through adsorption, a process where molecules adhere to the surfaces and pores of the carbon. The main forces involved are van der Waals forces, hydrophobic interactions, π-π stacking (between aromatic rings of compounds and the carbon basal planes), and electrostatic interactions (if the carbon surface or the pharmaceutical molecule carries a charge). Hydrogen bonding and covalent bonding can also occur in some cases, especially with chemically modified carbons.

The adsorption process is influenced by the properties of both the adsorbate (pharmaceutical) and the adsorbent (activated carbon). Key factors include the molecular size, shape, polarity, solubility, and ionization state of the pharmaceutical, as well as the pore size distribution and surface chemistry of the carbon. For instance, hydrophobic compounds (with high log Kow values) tend to adsorb more strongly onto hydrophobic carbon surfaces, while ionic compounds may show pH-dependent adsorption due to electrostatic attraction or repulsion. Understanding these mechanisms helps in selecting the appropriate type of activated carbon for a given wastewater matrix.

Adsorption Isotherms

The relationship between the amount of pharmaceutical adsorbed and its concentration in solution at equilibrium is described by adsorption isotherms, such as the Langmuir and Freundlich models. These models provide insights into the adsorption capacity and the affinity between the pharmaceutical and the carbon. High-affinity adsorption means that even at low concentrations, a significant fraction of the compound can be removed—important for achieving the low residual concentrations required for regulatory compliance.

Factors Influencing Adsorption Efficiency

1. Pharmaceutical Properties

Molecular weight, structure, and functional groups determine whether a compound can enter the pores and bind effectively. Larger molecules may be excluded from micropores. Nonpolar, aromatic compounds (e.g., many antibiotics) generally adsorb well due to hydrophobic and π-π interactions. Ionizable compounds (e.g., ibuprofen, sulfamethoxazole) show adsorption dependence on pH, which affects both the compound's charge and the carbon's surface charge.

2. Water Chemistry Parameters

  • pH: Affects the ionization state of pharmaceuticals and the surface charge of activated carbon. For example, acidic pharmaceuticals are better adsorbed at low pH when they are neutral, while basic pharmaceuticals are better adsorbed at high pH.
  • Dissolved organic matter (DOM): Natural organic matter in wastewater competes for adsorption sites and can block pores, reducing pharmaceutical removal efficiency. This is one of the main challenges in real wastewater applications.
  • Temperature: Adsorption is generally exothermic, so lower temperatures may favor adsorption, but the effect is often small compared to other factors.
  • Ionic strength: High salt concentrations can affect electrostatic interactions and may either enhance or inhibit adsorption depending on the system.

3. Activated Carbon Characteristics

As mentioned, pore structure and surface chemistry are critical. Carbons with a high proportion of mesopores are better for larger pharmaceutical molecules. Surface oxidation can introduce oxygen-containing groups that increase hydrophilicity, possibly reducing adsorption of hydrophobic compounds but enabling new interactions for polar compounds. Carbons with basic surface groups (e.g., through ammonia treatment) can enhance adsorption of acidic compounds.

4. Operational Conditions

Contact time, adsorbent dose, and mixing affect the rate and extent of adsorption. In continuous flow systems (e.g., fixed-bed columns), flow rate and bed depth influence breakthrough time. For powdered activated carbon (PAC) added to treatment tanks, the dose and contact time must be optimized to achieve desired removal without excessive carbon usage.

Types of Activated Carbon Used in Wastewater Treatment

Powdered Activated Carbon (PAC)

PAC consists of fine particles (typically <0.1 mm) and is usually added directly to the treatment process as a slurry. It offers high surface area and fast kinetics due to small particle size. However, it cannot be easily regenerated and is typically disposed of after use (often incinerated). PAC is commonly used in drinking water treatment and can be integrated into existing activated sludge processes (e.g., in the PACT process) to enhance removal of micropollutants. Its main disadvantages are the need for separation from the treated water and the difficulty of regeneration.

Granular Activated Carbon (GAC)

GAC has larger particle sizes (typically 0.4–2.5 mm) and is used in fixed-bed or moving-bed columns. Water flows through the GAC bed, and the carbon can be regenerated on-site using thermal methods and reused. GAC systems are widely used for tertiary treatment in wastewater plants and for advanced water purification. The main advantages are reusability and ease of operation, but the capital cost can be higher. GAC is especially suitable for treating large volumes of water with moderate contaminant loads.

Other Forms: Extruded and Impregnated Carbons

Extruded activated carbon (EAC) is formed by extruding a mixture of powdered carbon and a binder into cylindrical pellets. These have higher mechanical strength and lower pressure drop in columns. Impregnated activated carbons are modified with chemicals (e.g., silver, iodine, or metal oxides) to target specific contaminants. For pharmaceutical removal, chemically modified carbons (e.g., with iron oxides to enhance magnetic separation, or with functional groups to target specific pharmaceuticals) are an area of active research.

Regeneration and Reuse of Spent Activated Carbon

One of the attractive features of activated carbon, especially GAC, is the potential for regeneration and multiple uses. Regeneration reduces waste and operational costs. The most common method is thermal regeneration, where spent carbon is heated to 800–1,000 °C in a controlled atmosphere. This process volatilizes or gasifies adsorbed organics, restoring the pore structure. However, thermal regeneration can lead to some loss of carbon (5–10% per cycle) and changes in pore size distribution.

Alternative Regeneration Methods

  • Chemical regeneration: Using solvents, acids, or bases to desorb pharmaceuticals. This is less energy-intensive but can generate secondary waste and may be less effective for strongly bound compounds.
  • Biological regeneration: Microorganisms can degrade adsorbed organics, effectively cleaning the carbon. This approach is still experimental for pharmaceuticals but shows promise for some biodegradable compounds.
  • Electrochemical regeneration: Applying an electric current to oxidize adsorbed contaminants. This method is emerging and offers potential for in-situ regeneration without removing the carbon from the reactor.
  • Microwave regeneration: Using microwave energy to heat the carbon quickly and selectively, reducing energy consumption compared to conventional thermal methods.

The choice of regeneration method depends on the nature of the adsorbed pharmaceuticals, the carbon type, and economic factors. For some applications, especially with PAC, regeneration may not be cost-effective, and the spent carbon is disposed of in landfills or incinerated.

Comparison with Other Treatment Technologies

Activated carbon is not the only option for pharmaceutical removal. Other advanced treatment processes include ozonation, advanced oxidation processes (AOPs), membrane filtration (nanofiltration and reverse osmosis), and biological treatment with specialized microorganisms. Each has its strengths and weaknesses.

Ozonation

Ozone can effectively oxidize many pharmaceutical compounds, but it can also form harmful byproducts (e.g., bromate in bromide-containing waters) and may not achieve complete mineralization. Ozonation is often combined with activated carbon or biological post-treatment to remove byproducts.

Advanced Oxidation Processes (AOPs)

AOPs (e.g., UV/H2O2, Fenton, photocatalysis) generate highly reactive hydroxyl radicals that can degrade almost any organic contaminant. They are powerful but energy-intensive and may require chemical additives. Byproducts can be a concern, and the process is less established for large-scale municipal wastewater treatment.

Membrane Filtration

Nanofiltration and reverse osmosis can reject a high percentage of pharmaceuticals, producing a clean permeate. However, membranes are prone to fouling, require high pressure, and generate a concentrated retentate that must be further treated. The capital and operational costs are higher than activated carbon for many applications.

Biological Treatment

Some pharmaceuticals are biodegradable, and specialized bacteria or fungi can be used to degrade them. However, many compounds are recalcitrant, and biological processes may not achieve low enough effluent concentrations. Combining activated carbon with biological treatment (e.g., in the PACT process or as a post-treatment biofilter) can synergistically remove both biodegradable and non‑biodegradable pharmaceuticals.

Overall, activated carbon offers a balance of effectiveness, cost, and simplicity, particularly for removing a broad spectrum of pharmaceuticals. It can be implemented as a stand-alone tertiary treatment or integrated into existing systems.

Case Studies and Real-World Applications

Several wastewater treatment plants have successfully implemented activated carbon for pharmaceutical removal. For example, the Neugut WWTP in Switzerland (one of the first to use GAC for micropollutant removal under the Swiss Water Protection Act) achieved removal rates >80% for many pharmaceuticals. Similarly, the Berliner Wasserbetriebe has employed PAC in a tertiary contact reactor, demonstrating consistent reduction of diclofenac, carbamazepine, and sulfamethoxazole.

In pilot studies, researchers have tested activated carbon in combination with ozonation. The EU project DEMEAU (2012–2015) evaluated GAC filtration in full-scale at several European sites and reported that GAC could effectively remove most pharmaceuticals for up to several months before breakthrough. The duration of effective removal depended on the carbon type, water quality, and concentration of organic matter. These real-world examples show that activated carbon is a viable technology, but site-specific optimization is essential.

For more detailed information, consult the EPA’s resource on contaminants of emerging concern and the WHO fact sheet on pharmaceuticals in drinking water.

Challenges and Limitations

While activated carbon is effective, several challenges must be addressed to maximize its potential in removing pharmaceuticals from wastewater.

  • Competition from natural organic matter: DOM in wastewater can significantly reduce the adsorption capacity for pharmaceuticals by occupying pores and binding sites. This competition is one of the main limitations, particularly in secondary effluents with high DOM levels.
  • Variability in pharmaceutical composition: Wastewater contains a complex mixture of hundreds of pharmaceutical compounds, each with different adsorption characteristics. A single activated carbon type may not be optimal for all compounds, and design must target the most concerning or prevalent ones.
  • Saturation and breakthrough: Over time, the carbon becomes saturated and must be replaced or regenerated. The breakthrough time—when effluent concentration exceeds a target level—is unpredictable without proper monitoring and modeling.
  • Disposal of spent carbon: If not regenerated, spent carbon containing concentrated pharmaceuticals becomes a hazardous waste that requires careful handling, incineration, or landfill disposal with leachate control.
  • Cost: While less expensive than membranes or AOPs for many cases, the cost of activated carbon procurement and regeneration can still be significant for large plants. Economic feasibility depends on local energy costs, carbon prices, and regulatory requirements.

Future Research Directions

To enhance the performance of activated carbon for pharmaceutical removal, researchers are exploring several innovative approaches.

1. Tailored Activated Carbons

Modifying the surface chemistry or pore structure to target specific pharmaceutical families. For example, introducing nitrogen-containing groups to enhance adsorption of acidic pharmaceuticals, or creating hierarchical pore structures to improve mass transfer.

2. Composite and Hybrid Materials

Combining activated carbon with other materials, such as metal–organic frameworks (MOFs), magnetic nanoparticles (for easy separation), or biochar, to create composites with synergistic properties. Magnetic activated carbon can be recovered using magnetic fields, simplifying regeneration in PAC systems.

3. Integration with Biological Processes

Using activated carbon as a support for biofilms (e.g., in biological activated carbon filters) to combine adsorption and biodegradation. This approach can extend the life of the carbon by allowing attached microorganisms to degrade adsorbed pharmaceuticals in situ.

4. Advanced Regeneration Techniques

Developing more efficient and less energy-intensive regeneration methods, such as electrochemical or microwave regeneration, to reduce operational costs and carbon losses.

5. Real-Time Monitoring and Modeling

Using sensors and predictive models to optimize carbon usage, predict breakthrough, and automate regeneration cycles. Machine learning algorithms are being developed to forecast adsorption performance based on water quality and operational data.

Conclusion

Activated carbon offers a proven and adaptable solution for removing pharmaceuticals from wastewater. Its high adsorption capacity, relatively low cost, and ability to be regenerated make it an attractive option for treating micropollutants that escape conventional treatment. However, successful implementation requires careful consideration of water chemistry, carbon type, and operational parameters. Challenges such as competition from natural organic matter, variability in compound removal, and spent carbon disposal must be addressed through research and engineering innovation.

As regulatory pressure to reduce pharmaceutical contaminants grows—exemplified by the European Union’s revised Drinking Water Directive and the Swiss strategy on micropollutants—activated carbon will likely play an increasingly central role in wastewater treatment. By combining activated carbon with other technologies and advancing our understanding of adsorption mechanisms, we can move toward more efficient and sustainable water purification that protects both human health and aquatic ecosystems.

For further reading, see the critical review of adsorption of pharmaceuticals from aqueous solutions in Environmental Science & Technology, and the practical guide from Water Online on activated carbon for micropollutant removal.